Menveo Intramuscular Injection, Form : Liquid

Menveo is a meningococcal (groups A, C, Y, and W-135) conjugate vaccine used to protect against invasive meningococcal disease caused by Neisseria meningitidis. It is indicated for active immunization in individuals aged 2 months and older to prevent meningococcal infections, which can lead to life-threatening conditions like meningitis and septicemia. The vaccine stimulates the immune system to produce antibodies against the bacteria, reducing the risk of severe infection. Menveo is administered via intramuscular injection and is especially recommended for individuals at high risk, including travelers to endemic areas, military personnel, and those with certain medical conditions